- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02124343
Exercise and Neutrophil Function in COPD
A Pilot Study to Examine the Effect of Acute Exercise on Neutrophil Function in Patients With Chronic Obstructive Pulmonary Disease
Exercise is a cornerstone of pulmonary rehabilitation in the treatment of Chronic Obstructive Pulmonary Disease (COPD). Although researchers have shown numerous benefits with exercise in COPD patients, most studies have only looked at exercise tolerance and psychological outcomes following training. COPD is characterised by persistent inflammation that can cause progressive decline in lung function and multisystemic complications. This inflammation can be amplified in patients when they suffer acute exacerbations. There is a wellknown relationship between exercise, immune function and risk of infection. Exercise has also been shown to have an antiinflammatory effect when performed regularly. There is a lack of research looking into the inflammatory or immune response to exercise in patients with COPD. The exercise within this study will be individually tailored to patients with COPD based on their validated 6 minute walk test (6MWT) but the protocol will involve interval exercise that has been used previously. This type of exercise is considered most appropriate for research into mechanisms of benefit because it maintains the exercise training effects of other modalities (e.g. continuous low intensity aerobic exercise) while avoiding the occurrence of limitations to exercise in people with lung problems (e.g. dynamic hyperinflation). It also closely mirrors daily activity of someone with COPD.
The investigators want to explore the effects of exercise specifically on immune function in 15 people COPD and compare any changes to 15 Controls. By better understanding the mechanisms of how exercise affects inflammation, the investigators could eventually design better Pulmonary Rehabilitation interventions, especially for those most at risk.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Carmarthenshire
-
Llanelli, Carmarthenshire, United Kingdom, SA14 8QF
- Prince Philip Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- COPD group - 15 Participants who have been diagnosed with any severity of COPD (according to BTS criteria, i.e. >10 pack-year smoking history and post-bronchodilator spirometry FEV1/FVC ratio <0.70 and FEV<80%) and have completed at least 12 from 18 sessions of a pulmonary rehabilitation programme.
- Age 50-80 years.
- Current non-smoker.
- Control group - 15 Participants who will act as Controls, without COPD or cardiovascular disease
- Age 50-80 years (ideally of similar gender distribution)
- Current non-smoker.
- Spirometry: FEV1/FVC>0.7 and FEV>80% predicted
Exclusion Criteria:
- Known asthma or allergic rhinitis or other respiratory disease (bronchiectasis, pulmonary fibrosis).
- A change in any medications within 4 weeks or during the study.
- Require domiciliary oxygen.
- Acute exacerbation of COPD within 4 weeks of study entry.
- Any infection or illness within 4 weeks of study entry.
- Other active inflammatory conditions e.g. rheumatoid arthritis, cancer, unstable cardiac conditions.
- Receiving oral steroids or other immunomodulating drugs.
- Currently undergoing exercise training (including Pulmonary Rehabilitation).
- Any previous cardiovascular contraindications to exercise (e.g. unstable angina).
- Inability to complete the 6MWT due to physical or mental impairment.
- Exhaled CO>10ppm or smoked any cigarettes within 6 months.
- Inability or unwillingness to sign informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interval Exercise
Subjects will undertake an interval exercise session (on a harnessed treadmill) (HP Cosmos Mercury 4.0, HP Cosmos Sports and Medical Gmbh, Nussdorf-Traustein,Germany) based on the average speed calculated from the 6 minute walk test (6MWT). Intervals are based on the work previously done by Mador et al., 2009 who used intervals of 150% (for 1 minute) followed by intervals of 75% (for 2 minutes) based on 80% average speed from the 6 minute walk test. This study repeated these intervals 7 times with a duration of 23 minutes in total for the exercise intervention with the 75% intervals at the start and at the end of the exercise session. No warm up was undertaken for this method as it was a walking exercise test and the risk of injury was minimised with use of the harnessed treadmill. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neutrophil response to exercise
Time Frame: 4 months
|
The primary outcome measure for this study is to examine neutrophil responses to acute exercise, including changes in the counts and function of these cells in blood and sputa in order to compare any changes between COPD and age-gender matched controls.
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Different health status and the responses on neutrophil function
Time Frame: 4 months
|
The secondary outcome measures for this study is to examine the responses of inflammatory (pro and anti) mediators (e.g.
cytokines) to acute exercise.
|
4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of inhaled steroids on neutrophil response following exercise
Time Frame: 4 months
|
The third outcome for this study is to compare neutrophil response to exercise in those taking different types of inhaled steroid (fluticasone versus budesonide or beclamethasone).
|
4 months
|
|
Neutrophil response to exercise in past smokers versus non-smokers
Time Frame: 4 months
|
The fourth outcome measure of this study is to compare neutrophil response to exercise in past smokers versus non-smokers.
|
4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alex R Jenkins, BSc (Hons), Aberystwyth University
- Study Chair: Keir E Lewis, MD, Hywel Dda Health Board
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14/WA/0022
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Airway Disease
-
University of LeedsThe Leeds Teaching Hospitals NHS TrustRecruitingAirway DiseaseUnited Kingdom
-
University of MilanIRCCS Azienda Ospedaliero-Universitaria di Bologna; Valduce Hospital; Ente Ospedaliero... and other collaboratorsCompletedAcute Exacerbation of Chronic Obstructive Airways DiseaseItaly, Switzerland
-
Maastricht University Medical CenterAstraZeneca; Center for Integrated Rehabilitation and Organ Failure HornUnknownChronic Obstructive Airway DiseaseNetherlands
-
Psykiatrien SydNaestved HospitalCompleted
-
Swedish Intensive Care RegistryCompletedCritical Care | Chronic Obstructive Airways Disease ExacerbatedSweden
-
Ludwig-Maximilians - University of MunichUnknownEnd Stage Chronic Obstructive Airways DiseaseGermany
-
Synapse BiomedicalCompletedChronic Obstructive Airway DiseaseBelgium
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Airway DiseaseGermany
-
Imperial College LondonAsthma UKWithdrawnHealthy Volunteers | Chronic Obstructive Airway DiseaseUnited Kingdom
-
Ministry of Health and Population, EgyptCompleted
Clinical Trials on Interval Exercise
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedTachycardia, Ventricular | Defibrillators, ImplantableNorway
-
Rigshospitalet, DenmarkCompleted
-
University of GuelphCompletedPost-Exercise Hypotension | Ambulatory Blood Pressure Monitoring | High-intensity Interval ExerciseCanada
-
Ahlia UniversityCairo UniversityCompletedObesity | Diabetes | Exercise | Nonalcoholic Fatty Liver DiseaseEgypt
-
Laboratoire des Adaptations Métaboliques à l'Exercice...CREPS Auvergne Rhône-Alpes / VichyCompletedOverweight | PostmenopausalFrance
-
Norwegian University of Science and TechnologySt. Olavs Hospital; SINTEF Health ResearchCompleted
-
Arizona State UniversityTerminatedExercise | Central Blood PressureUnited States
-
Cairo UniversityCompletedArterial StiffnessEgypt